Episode 176: Preoperative Anti-VEGF, RD after Intravitreal Injection, and Influence of CATT Trial Results Straight From The Cutter's Mouth: A Retina Podcast
-
- Education
Dr. Ferhina Ali and Dr. M. Ali Khan join for a journal club discussion of three recent publications in major ophthalmology journals.
Articles discussed:
Preoperative anti-VEGF for diabetic vitrectomy (https://www.ajo.com/article/S0002-9394(19)30231-4/fulltext)
Retinal detachment after intravitreal injection (https://www.aaojournal.org/article/S0161-6420(18)33327-X/fulltext)
CATT Trial Effect on Anti-VEGF Usage (https://www.ajo.com/article/S0002-9394(19)30231-4/fulltext)
Dr. Sridhar has received fees for consulting for Alimera, Alcon, and Thrombogenics. Dr. Ali is a Genentech employee and stock holder and has consulted for Voyant biotherapeutics and Forsight. Dr. Khan has received fees for consulting from Allergan. Some podcast episodes now qualify for CME credits. To claim your credits visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.
Dr. Ferhina Ali and Dr. M. Ali Khan join for a journal club discussion of three recent publications in major ophthalmology journals.
Articles discussed:
Preoperative anti-VEGF for diabetic vitrectomy (https://www.ajo.com/article/S0002-9394(19)30231-4/fulltext)
Retinal detachment after intravitreal injection (https://www.aaojournal.org/article/S0161-6420(18)33327-X/fulltext)
CATT Trial Effect on Anti-VEGF Usage (https://www.ajo.com/article/S0002-9394(19)30231-4/fulltext)
Dr. Sridhar has received fees for consulting for Alimera, Alcon, and Thrombogenics. Dr. Ali is a Genentech employee and stock holder and has consulted for Voyant biotherapeutics and Forsight. Dr. Khan has received fees for consulting from Allergan. Some podcast episodes now qualify for CME credits. To claim your credits visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.